BryoLogyx

Bryo Logyx

Biotechnology, 36 Madison Ave, Danville, California, 07940, United States, 1-10 Employees

bryologyx.com

  • facebook
  • LinkedIn

phone no Phone Number: +15*********

Who is BRYOLOGYX

BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies. The company is capitalizing on two recent scientific advance...

Read More

map
  • 36 Madison Ave, Danville, California, 07940, United States Headquarters: 36 Madison Ave, Danville, California, 07940, United States
  • 2016 Date Founded: 2016
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

checked-icon Does something look wrong? Fix it. | View contact records from BRYOLOGYX

BryoLogyx Org Chart and Mapping

Employees

William Grossman

Board Member, Board of Directors

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding BryoLogyx

Answer: BryoLogyx's headquarters are located at 36 Madison Ave, Danville, California, 07940, United States

Answer: BryoLogyx's phone number is +15*********

Answer: BryoLogyx's official website is https://bryologyx.com

Answer: BryoLogyx's revenue is Under $1 Million

Answer: BryoLogyx has 1-10 employees

Answer: BryoLogyx is in Biotechnology

Answer: BryoLogyx contact info: Phone number: +15********* Website: https://bryologyx.com

Answer: BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies. The company is capitalizing on two recent scientific advances: the discovery that a complex natural product, bryostatin, stimulates tumor antigen production to amplify the immune response unleashed by cancer immunotherapy; and the invention of the first practical synthetic production method for bryostatin and analogs, enabling their availability for commercial development. BryoLogyx has licensed exclusive rights from Stanford University to the methods use in the areas of cancer, as well as in other areas including inflammatory, autoimmune, and infectious diseases (outside neurological and CNS diseases and psychiatric disorders). BryoLogyx is poised to initiate clinical studies in collaboration with the NCI. Bryostatin has an established safety profile based on prior clinical studies involving more than 1100 patients.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access